---
schema_version: "secwatch.filing_event.v1"
accession: "0001793229-22-000114"
form_type: "8-K"
ticker: "CTEV"
cik: "0001793229"
company_name: "Claritev Corp"
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T04:17:46.368979+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# MultiPlan Q3 revenue down 13% to $250.5M; net income falls 75%; slashes FY2022 guidance

## Summary
- Q3 revenue $250.5M (down 13.1% YoY); net income $19.7M (down 74.8%); adjusted EBITDA $172.2M (down 21.2%).
- FY2022 revenue guidance cut to $1,075-1,090M from $1,160-1,200M; adjusted EBITDA lowered to $765-780M from $850-875M.
- Drivers: softer patient utilization and unfavorable mix of medical cost savings; COVID impact estimated at $4-6M revenue.
- Free cash flow $88.2M vs $146.6M in Q3 2021, down 40%.
- Q4 2022 outlook: revenue $235-250M, adjusted EBITDA $155-170M.

## SEC filing metadata
- accession: 0001793229-22-000114
- form_type: 8-K
- ticker: CTEV
- cik: 0001793229
- company_name: Claritev Corp
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1793229/000179322922000114/0001793229-22-000114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1793229/000179322922000114/mpln-20221108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001793229-22-000114
- JSON: https://secwatch.observer/filing/0001793229-22-000114.json
- Plain text: https://secwatch.observer/filing/0001793229-22-000114.txt

## Key facts
- Earnings Releases
  Claritev Corp reported quarter ended September 30, 2022 results: revenue $250.5 million, net income $19.7 million. Guidance lowered.
  - Period: quarter ended September 30, 2022
  - Revenue: $250.5 million
  - Net income: $19.7 million
  - Guidance: lowered
  - Result: reported results
  source text: MultiPlan Reports Third Quarter 2022 Results and Updates 2022 Guidance – Q3 2022 Revenues of $250.5 million, Net Income of $19.7 million, and Adjusted EBITDA of $172.2 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1793229/000179322922000114/0001793229-22-000114-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.